Access cutting-edge endometrial cancer treatment through this clinical trial at a research site in Birmingham. Study-provided care at no cost to qualified participants.
Access endometrial cancer specialists in Birmingham at no cost
This study follows strict safety protocols and ethical guidelines
All study-related endometrial cancer treatment provided free
The purpose of this study is to evaluate the efficacy and safety of selinexor as a maintenance treatment in patients with p53 wt endometrial carcinoma (EC), who have achieved a partial response (PR) or complete response (CR) (per Response Evaluation Criteria in Solid Tumors version 1.1 \[RECIST v 1.1\]) after completing at least 12 weeks of platinum-based therapy. A total of 220 participants will be enrolled in the study and randomized in a 1:1 ratio to maintenance therapy with either selinexor
Sponsor: Karyopharm Therapeutics Inc
Check if you qualify for this endometrial cancer clinical trial in Birmingham, AL
If you're searching for endometrial cancer treatment options in Birmingham, AL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Birmingham research site is actively enrolling participants for this clinical trial. You'll receive care from experienced endometrial cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.